This High-Yield ETF Has Increased Payouts 11 Years Straight, and It's Still Undervalued
Key Points
ETFs that consistently deliver years of steady dividend growth are few and far between.
The simple, yet effective strategy used by the iShares Core Dividend Growth ETF is working.
It's overweight in key sectors, including financials and healthcare, which provides growth catalysts for the portfolio, as well as solid value.
- 10 stocks we like better than iShares Trust - iShares Core Dividend Growth ETF ›
Consistent dividend growth is a goal for many income investors. Exchange-traded funds (ETFs) aren't necessarily as good as individual stocks for predictable income because they're usually buying, selling, and rebalancing throughout the year. That can potentially interrupt dividend growth at inopportune times.
Some dividend ETFs, however, are still able to deliver a solid track record. Even with those possible hiccups, they've still been able to deliver years of steady dividend growth for investors. One fund that's been able to accomplish this is the iShares Core Dividend Growth ETF (NYSEMKT: DGRO). Since its inception in 2014, it's been able to increase its annual dividend payout every year.
Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now, when you join Stock Advisor. See the stocks »
How does it do it when so many other dividend ETFs fail? Let's break it down.
Image source: Getty Images.
What is the iShares Core Dividend Growth ETF?
The fund tracks the Morningstar U.S. Dividend Growth Index. It's comprised of dividend-paying stocks that meet three primary criteria:
- Must pay a qualified dividend.
- Must have five-plus years of consecutive dividend growth.
- Must have a payout ratio of less than 75%.
These criteria help accomplish a few things. First, they help ensure that the companies the fund invests in have committed to paying and increasing their dividends over time. Second, it screens companies to make sure they have a higher likelihood of sustaining that dividend growth. It's not a particularly stringent set of qualifying criteria, but it's enough to screen out many of the bad apples that can hurt dividend durability.
This strategy doesn't produce a portfolio that's as exciting as a tech ETF, but it does create one full of durable, successful companies that generate strong cash flows and steady earnings. Top holdings currently include ExxonMobil, JPMorgan Chase, Johnson & Johnson, Microsoft, and Apple.
Its expense ratio of 0.08% is among the lowest in this category, and its current yield of 2.14% is more than double that of the S&P 500 (SNPINDEX: ^GSPC).
More than a decade of dividend growth
The iShares Core Dividend Growth ETF's history shows not just increasing dividend payments, but payouts rising at a pretty healthy clip.
| Year | Per-Share Payout | Change | Year | Per-Share Payout | Change |
|---|---|---|---|---|---|
| 2014 | $0.257733 | N/A | 2020 | $1.028797 | 10.5% |
| 2015 | $0.647292 | 151% | 2021 | $1.071762 | 4.2% |
| 2016 | $0.656593 | 1.4% | 2022 | $1.167939 | 9% |
| 2017 | $0.705469 | 7.4% | 2023 | $1.315948 | 12.7% |
| 2018 | $0.810302 | 14.9% | 2024 | $1.385085 | 5.3% |
| 2019 | $0.930618 | 14.8% | 2025 | $1.450642 | 4.7% |
Data source: iShares.
The fund's 10-year annual dividend growth rate of approximately 8.6% easily eclipses the 5.6% dividend growth rate of the S&P 500. That kind of growth rate helps investors retain their purchasing power by growing their income higher than the rate of inflation.
Why the iShares Core Dividend Growth ETF is still undervalued
This fund trades at roughly a 21% valuation discount to the S&P 500, using the price-to-earnings (P/E) ratio as a measuring stick. That's largely a function of the difference in tech sector allocations. The iShares ETF only has about half the tech weighting that the index does, and overweights several sectors that historically come with lower valuations.
Its current trailing-12-month P/E ratio is around 20.6. That's higher than its 10-year median ratio of 18.3, but most funds are trading above their historical averages.
The one value argument I'm intrigued by right now is the heavier allocations to both financials and healthcare. These two sectors have been underperformers, but have potential catalysts in place that could turn them around.
For example, financials could benefit from a Federal Reserve that no longer looks like it's going to cut interest rates sharply in 2026. With the U.S. economy still growing and inflation stuck above the central bank's target, there simply isn't an incentive for the Fed to move rates much. Since higher rates mean higher margins for banks, we could see better financial performance ahead.
Healthcare could benefit from a potential deregulation trend. Regulatory oversight in the healthcare space can involve heavy compliance costs and hindrances to the sweep in which new developments, innovations, and medicines can be implemented and/or brought to market. The Trump administration has boasted that it took 646 deregulatory actions in fiscal year 2025, realizing more than $200 billion in cost savings. Healthcare has been a relatively modest beneficiary of this trend thus far, but the regulatory rollbacks at the Food & Drug Administration last year show that this sector is on the radar.
Overall, this ETF has a strong history of dividend growth, and its proven strategy of targeting companies with sustainable future dividend growth should help it to keep delivering for shareholders.
Should you buy stock in iShares Trust - iShares Core Dividend Growth ETF right now?
Before you buy stock in iShares Trust - iShares Core Dividend Growth ETF, consider this:
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and iShares Trust - iShares Core Dividend Growth ETF wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.
Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you’d have $489,300!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you’d have $1,159,283!*
Now, it’s worth noting Stock Advisor’s total average return is 974% — a market-crushing outperformance compared to 196% for the S&P 500. Don't miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.
See the 10 stocks »
*Stock Advisor returns as of January 8, 2026.
JPMorgan Chase is an advertising partner of Motley Fool Money. David Dierking has positions in Apple. The Motley Fool has positions in and recommends Apple, JPMorgan Chase, and Microsoft. The Motley Fool recommends Johnson & Johnson and recommends the following options: long January 2026 $395 calls on Microsoft and short January 2026 $405 calls on Microsoft. The Motley Fool has a disclosure policy.
Recommended Articles
